Mounjaro Tirzepatide Injection 5 Mg

Details

Mounjaro Tirzepatide Injection 5 mg is a dual GIP and GLP‑1 receptor agonist used for Type 2 Diabetes Mellitus and weight management. It improves glycemic control by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. The once‑weekly injectable is manufactured under GMP and WHO‑GMP certified facilities. Store refrigerated at 2–8 °C and protect from direct sunlight.